Skip to content

Evaluation of an open-label placebo appetite suppressant

Evaluation of an open-label placebo appetite suppressant

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037615
Enrollment
55
Registered
2025-08-04
Start date
2025-08-25
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: Within-subject design in which the subjects participate once with (arm 1: intervention condition) and once without (arm 2: control condition) open-label placebo intervention. Group 2: The sam

Sponsors

Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 18 Years

Inclusion criteria

Inclusion criteria: Participants have to ba able to see food images on a screen (normal or corrected-to-normal vision).

Exclusion criteria

Exclusion criteria: eating disorders (self-reported)

Design outcomes

Primary

MeasureTime frame
Comparison of the two conditions with regard to: 1. Time course of appetite (desire to eat) across food image exposure (all 20 trials) 2. Wanting and liking of depicted foods that can be both high in sugar and low in sugar. 3. Desire for sweet taste 4. Eye movement data The evaluation of this data will correspond to that in this publication: https://doi.org/10.1016/j.appet.2024.107820

Secondary

MeasureTime frame
Sequence effects (whether the open-label placebo condition or the control condition is performed first) as well as effects of the experimenter and effects of age (of participant) are analysed exploratively.

Countries

Austria

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.at+43 316 380 5086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026